newsfilter
← Latest News
GlobeNewswire·

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

WALTHAM, Mass. and BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (NASDAQ:MASS), a pioneer in